Tuberculosis
Pradhan Mantri TB Mukt Bharat Abhiyaan
Tuberculosis (TB) is one of India’s major public health problems. According to World Health Organization (WHO) estimates, India has the world’s largest tuberculosis epidemic. In 2023, India has incidence rate of 199 cases per 100,000 of population. India aims to completely eliminate TB by 2025 through the Pradhan Mantri TB Mukt Bharat Abhiyaan. This is a social initiative to augment community involvement in meeting India’s commitment to end TB and leveraging Corporate Social Responsibility (CSR) activities. The Abhiyaan endeavors at increasing awareness among the public regarding TB, engaging community in active case finding, supporting the treatment cascade, reducing stigma related to TB and nutrient supplementation to reduce out-of-pocket expenditure for the family of the TB patient.
Our Work
Transforming 1000 Villages across India as ‘TB Free Villages’
The USEA trust is committed to ‘Pradhan Mantri TB Mukt Bharat Abhiyaan’ to end TB in 1000 villages by fostering community ownership of actions to end TB and mobilizing local administration’s commitment for TB free initiatives. The TB-Free Village intervention is in alignment with the ‘TB Mukt Panchayat Initiative’ launched by the Hon’ble Prime Minister of India at the World TB Day Event on 24 March 2023. The TB Mukt Panchayat Initiative is being promoted as one of the key strategies to make every small geography/ panchayat TB-free to achieve the overarching goal of TB elimination in India.
The USEA project supported by JSW Foundation kickstarted on 25 August 2023 at Aarogya Bhavan, Raigad, Maharashtra. The event was inaugurated by Shri Dheeraj Kumar Commissioner (HS) & MD (NHM) and attended by Dr. Sunita Golhait, Joint Director Health Services, Dr.Asheesh Jain, Head Health and Nutrition JSW Foundation, Dr. Jadhav, District TB Officer-Raigad and Dr. Shankar Dapkekar (National Lead -Team USEA). The shared vision and interventions in alignment with PM’s TB free India by 2025 included screening, testing and treatment through early diagnosis of TB patients. The key pillars include an innovative approach of door-to-door screening using AI apps and hand held Xray (supported by MyLab).
